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Purpose: Aortic stiffness (AS) is associated with cardiovascular events and all-cause
mortality in the older population. AS might also inﬂuence the health-related quality of life
(HRQOL) as a result of the negative effects of AS on cognitive and physical morbidity. We
aimed to investigate the possible association between AS and HRQOL in people aged 75
years and over.
Patients and Methods: This cross-sectional study was part of the SCOPE study, an
international multicenter cohort observational study. The indicators for AS were aortic
pulse wave velocity (aPWV) and central pulse pressure (cPP). HRQOL was assessed using
the EQ-5D index and the EQ-5D visual analog scale (VAS). ANCOVA and multivariate
regression models were used to investigate possible associations.
Results: We included 280 Dutch participants of the SCOPE study. Median age was 79 years
(IQR 76–83) and 42.1% were women. Participants reporting any problem on the EQ-5D
index (n=214) had higher values of aPWV (12.6 vs 12.2 m/s, p = 0.024) than participants not
experiencing any problem (n=66) and comparable values of cPP (44.4 vs 42.0 mmHg, p =
0.119). Estimates only slightly changed after adjustments. No association was found between
indicators of AS and EQ-5D VAS.
Conclusion: Aortic stiffness was associated with impaired quality of late life. This associa-
tion could be mediated by subclinical vascular pathology affecting mental and physical
health.
Keywords: arterial stiffness, health-related quality of life, EQ-5D, older persons
Introduction
Aortic stiffness is a part of vascular aging,1–3 a phenomenon which can be accelerated
by risk factors such as hypertension and diabetes mellitus.4–9 Aortic stiffness is
a powerful predictor of cardiovascular events and all-cause mortality in several clinical
populations as well as in community-dwelling older people.10–12 Aortic stiffness is also
associated with microvascular brain disease,13,14 which can lead to decreased mental
health in terms of cognition, mood, and daily functioning.15,16 As a result of these
effects, aortic stiffness might also have a negative impact on quality of life. The
negative impact of aortic stiffness on quality of life could be a subclinical result of
vascular pathology or a result of the presence of comorbidities.17–20
Previous studies have investigated the possible association between aortic
stiffness and quality of life in several study populations.21–27 These studies
show conﬂicting results. Moreover, to the best of our knowledge, no previous
study has investigated the possible association between aortic stiffness and the
quality of late life.
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Studying quality of life is relevant, since quality of life
is a more powerful predictor of morbidity and mortality
than many objective measures of health.28 Health-related
quality of life (HRQOL) can be seen as a broad measure of
health status and a supplement to traditional parameters as
morbidity and mortality.
The objective of this study was to determine whether
there is an association between aortic stiffness and quality
of life in older persons aged 75 years and over.
Materials and Methods
Study Population
The Screening for Chronic kidney disease among Older
People across Europe (SCOPE) study is a multicenter obser-
vational study with a prospective design in seven European
countries.29 The primary objective of the study is to investi-
gate the currently available screening methods to identify
community-dwelling older patients at risk of kidney disease.
A detailed description of the study protocol can be found
elsewhere.29 Patients with end-stage renal disease or dialysis,
a history of solid organ or bone marrow transplantation, an
active malignancy or metastatic cancer within 24 months
prior to the visit, a life expectancy of less than 6 months,
a severe cognitive impairment or patients unwilling to pro-
vide consent were ineligible for the SCOPE study. The
current study population was a subset of the SCOPE study
population including only the Dutch participants (n=301).
Data on aortic stiffness were only collected at participating
centers in the Netherlands. The SCOPE study has been
reviewed and approved by the Medical Ethics Committee
of the ErasmusMCUniversityMedical Center. This trial was
conducted in accordance with the Declaration of Helsinki.
This study was registered on the 25th February 2016 at
clinicaltrials.gov, identiﬁer NCT02691546. All participants
provided written informed consent.
Study Visit
Baseline visit was scheduled at the Erasmus Medical
Center Rotterdam or at the Havenziekenhuis Rotterdam.
A comprehensive geriatric assessment was performed accord-
ing to the SCOPE study protocol.29 The assessment included
questionnaires, physical examination, and functional tests.
Also, non-fastened blood and urine samples were taken.
Aortic Stiffness
Aortic stiffness was determined measuring aortic Pulse
Wave Velocity (aPWV) with the Mobil-O-Graph (IEM,
Rheinland, Germany), a previously validated oscillometric
method.30 aPWV measurements were performed by a single
measurement in resting sitting position using a brachial
cuff. Other hemodynamic parameters that were obtained
during the same measurement using inbuilt algorithms
included blood pressure (both peripheral and central),
mean arterial pressure (MAP), and heart rate (HR). In
addition to aPWV, central pulse pressure (cPP) was also
used as indicator of aortic stiffness.31,32 cPP was deﬁned as
the difference between central systolic blood pressure (SBP)
and central diastolic blood pressure (DBP). The measure-
ment was carried out in every participant. However, we
excluded participants in which the device was not able to
conduct a proper wave analysis due to technical issues.
Health-Related Quality of Life
The Euro QoL-5-dimensions (EQ-5D) questionnaire was
used to measure HRQOL.33 The 5-level EQ-5D question-
naire has been validated in a variety of patient groups in six
different countries, including the Netherlands.34 The ques-
tionnaire consists of two parts: a descriptive proﬁle and
a visual analogue scale (VAS). The descriptive part of the
questionnaire provides information on the following ﬁve
dimensions: mobility, self-care, daily activities, pain and
discomfort, and anxiety and depression. A ﬁve-level Likert
scale from no problems to being unable to function on the
speciﬁc domain was used to gather information about the
speciﬁc domains. This information was then converted into
a single index value that informs on the overall HRQOL.35
To calculate the EQ-5D index, a formula is used that weighs
each dimension value with a tariff speciﬁc for the country at
stake. The Dutch tariff was used in this study.36 The index
value is depicted on a scale with 0 indicating death and 1
indicating full health. The EQ-5D VAS is a 20 cm scale from
0 to 100 in which respondents can ﬁll out their current state of
health. Zero equals the worst imaginable health status and
100 the best imaginable health status.
Statistical Analysis
Statistical analyses were performed using IBM SPSS
Statistics version 24 for Windows. Participants with missing
values for the aortic stiffness parameters were excluded.
Descriptive statistics were expressed as percentage for cate-
gorical variables, mean and standard deviation (±SD) for
continuous normally distributed variables, and median and
interquartile ranges [IQR] for continuous non-normally dis-
tributed variables. Participants with an EQ-5D index value
of 1 were classiﬁed as “no problem on any dimension”
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(group 1), participants with an EQ-5D index value lower
than 1 were classiﬁed as “any problem on the ﬁve dimen-
sions” (group 2). First, characteristics were compared
between these groups using the Mann–Whitney U-test and
t-test for continuous variables. The Chi-square test was used
to compare percentages. An analysis of covariance
(ANCOVA) was used to investigate the possible association
between aortic stiffness and the dichotomized version of
EQ-5D index. Mean levels of aPWV and cPP were com-
pared between these groups using two different models.
Mean levels of pDBP and cDBP were also compared
between these groups. We have identiﬁed potential covari-
ates and included covariates with a p-value < 0.1 in the
adjusted models when appropriate. Model 1 was adjusted
for age, sex, mean arterial pressure and heart rate. Model 2
was additionally adjusted for Cumulative Illness Rating
Scale (total score). A multivariable linear regression
model was built to investigate the possible association
between aortic stiffness (aPWV and cPP) and the EQ-5D
VAS using the same models. A p-value of <0.05 was
considered statistically signiﬁcant.
Results
In total, 280 of the 301 Dutch participants were included in
the study, 21 participants were not included due to missing
values of aortic stiffness. Characteristics are shown in
Table 1. Median age was 79 years [IQR 76–83] and
42.1% were women. Few participants were ADL dependent
(15.4%) and 48.6% of the participants were iADL depen-
dent. Over 70% of the 280 participants had hypertension,
26.4% diabetes mellitus, 23.6% a history of malignancy,
21.1% COPD, 20.4% a history of stroke and 17.1% atrial
ﬁbrillation. The mean score on the cumulative illness rating
scale (CIRS) was 12.8±4.9 and the mean severity index of
the CIRS was 1.8±0.3. The maximum value of 1 on the EQ-
5D index (no problems) was scored by 66 participants
(23.6%). Participants reporting any problem on the EQ-5D
index (76.4%) were older, more often women, more often
iADL dependent, had higher scores on the geriatric depres-
sion scale and also higher comorbidity rates than those
without problems on the EQ-5D index, which resulted in
a higher CIRS total score (mean values 13.4±4.9 vs 10.9
±4.4, p < 0.001). Characteristics stratiﬁed for problems on
the EQ-5D index are also presented in Table 1.
Participants with any problem on the EQ-5D index had
lower peripheral (pDBP) and central DBP (cDBP) than
participants without problems on the EQ-5D index. Mean
values were 84.1±10.9 vs 88.4±11.8 mmHg (p=0.006) and
85.7±11.0 vs 90.3±11.8 mmHg (p=0.004), respectively.
Also, participants with any problem on the EQ-5D index
had higher values of aPWV than participants without
problems on the EQ-5D index (p=0.024). Mean values
were 12.6±1.3 and 12.2±0.9 m/s, respectively.
Table 2 shows the characteristics of the EQ-5D outcome
measures. Median EQ-5D index was 0.86 [IQR 0.81–0.91]
and the mean EQ-5D VAS was 74.9±14.8. No problems
were reported by 42.5% of participants on mobility, 92.5%
on self-care, 78.9% on daily activities, 44.6% on pain and
discomfort, and 83.6% on anxiety and depression.
Figure 1 shows themean levels of aortic stiffness according
to EQ-5D index status (no problemvs any problem). Themean
values of aPWVwere higher in the any problem group than in
the no problem group (12.52 m/s vs 12.39 m/s, p = 0.024). In
model 2, the mean aPWV values remained unchanged with
a 0.12 m/s higher mean aPWV in the group with any problem
(p = 0.041). Themean values of cPPwere 3.3mmHg higher in
the any problem group than in the no problem group (44.6
mmHg vs 41.3 mmHg, p = 0.042). This difference persisted in
model 2 (44.6 mm Hg vs 41.2 mmHg, p = 0.041).
Mean levels of pDBP and cDBP were also compared
between the two groups (no problem vs any problem).
However, in multivariate analysis in both model 1 and
model 2, mean values did not differ between groups (data
not shown). A trend was observed between aPWV and EQ-
5D VAS in model 1. Per m/s increase in aPWV, the EQ-5D
VAS score changed with −4.15 (95% CI −8.71–0.42),
whereas no association was found in model 2. No associa-
tion was found between cPP and the EQ-5D VAS. In model
1, B coefﬁcient and 95% CI for cPP were −0.05 (−0.21–
0.11); Estimates in model 2 were only slightly changed.
Discussion
In this exploratory study, we found that aortic stiffness,
assessed as aortic pulse wave velocity and central pulse
pressure, was associated with an impaired quality of life in
people of 75 years and over. This association in late life was
independent of age, blood pressure levels, and comorbidities.
Several mechanisms might explain our results. First, the
association between aortic stiffness and quality of late life
could be mediated by impaired physical health. Aortic stiff-
ness is known to play an important role in the development
and progression of diseases in end-organs and the presence of
these diseases could affect the quality of life.37 However, the
association between aortic stiffness and quality of life per-
sisted even after adjustment for cumulative comorbidities
suggesting an independent role of aortic stiffness. Second,
Dovepress Tap et al
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impaired mental health could also mediate the association
between aortic stiffness and quality of life. Elevated aortic
stiffness can lead to cerebral small vessel disease, which is
associated with cognitive decline as well as mood
disturbances.15,38–40 It is very well possible that quality of
life questionnaires might be able to detect vascular pathology
already in a subclinical stage. Subclinical vascular damage
could be already revealed in measures of quality of life
before it results in multiple physical and mental comorbid-
ities. An increase in aPWV of 1 m/s ampliﬁes the risk of
cardiovascular morbidity and mortality as well as all-cause
mortality by 15%.10 In this study, we found 0.12 m/s higher
aPWVand 3.4 mmHg higher cPP in participants with poorer
quality of life indexes. Although an increase in aPWV of
0.12 m/s or 3.4 mmHg higher cPP may seem relatively
modest and the effect size is small, these differences could
already have an impact on daily functioning, both physically
and mentally. Therefore, aortic stiffness might be a tissue
biomarker reﬂecting the vitality status of the single indivi-
dual. In addition, aortic stiffness determines high mean SBP
levels and low DBP levels, and consequently a wide pulse
pressure.41 It can be speculated that aortic stiffness together
with consequent aberrant hemodynamic changes can affect
quality of life by determining cardiovascular morbidity. It
Table 1 Participants’ Characteristics (n=280)
Characteristics Total No Problem EQ-5D
Index (n=66)
Any Problem EQ-5D
Index (n=214)
p-value
Age, years 79 [76–83] 78 [76–81] 79 [76–84] 0.047
Women, % 42.1 28.8 46.3 0.012
Education, years 12.1 (±4.5) 12.7 (±4.9) 11.9 (±4.4) 0.179
Packyears of smoking, years 5 [0–20] 3.9 [0–20] 6 [0–20.4] 0.528
Current smoker, % 5.0 3.0 5.6 0.824
Alcohol consumption ≥1 unit a day, % 34.3 39.4 32.7 0.317
BMI, kg/m2 26.3 (±4.3) 26.1 (±3.3) 26.3 (±4.5) 0.760
ADL dependent, % 15.4 9.1 17.3 0.106
iADL dependent, % 48.6 25.8 55.6 <0.001
MMSE, score 29 [27–30] 28 [27–30] 29 [27–30] 0.988
GDS, score 2 [1–3] 0 [0–1] 2 [1–4] <0.001
eGFR-BIS, mL/min 47.2 (±13.6) 46.6 (±13.1) 47.3 (±13.8) 0.701
Hypertension, % 70.7 62.1 73.4 0.079
Diabetes Mellitus, % 26.4 27.3 26.2 0.859
History of TIA/CVA, % 20.4 15.2 22.0 0.230
Atrial ﬁbrillation, % 17.1 10.6 19.2 0.107
COPD, % 21.1 10.6 24.3 0.017
History of malignancy, % 23.6 15.2 26.2 0.065
CIRS, total score 12.8 (±4.9) 10.9 (±4.4) 13.4 (±4.9) <0.001
CIRS, severity index 1.8 (±0.3) 1.8 (±0.3) 1.9 (±0.3) 0.271
Vascular Parameters
pSBP, mmHg 146.1 (±20.2) 148.2 (±20.3) 145.4 (±20.1) 0.337
pDBP, mmHg 85.1 (±11.2) 88.4 (±11.8) 84.1 (±10.9) 0.006
MAP, mmHg 113.0 (±14.0) 115.8 (±14.8) 112.2 (±13.6) 0.068
pPP, mmHg 60.9 (±15.5) 59.7 (±13.8) 61.2 (±16.0) 0.509
Heart rate, bpm 69.8 (±12.2) 70.5 (±12.9) 69.5 (±11.9) 0.579
cSBP, mmHg 130.6 (±17.4) 132.2 (±16.6) 130.1 (±17.6) 0.395
cDBP, mmHg 86.7 (±11.3) 90.3 (±11.8) 85.7 (±11.0) 0.004
cPP, mmHg 43.8 (±12.8) 42.0 (±10.1) 44.4 (±13.5) 0.119
aPWV, m/s 12.5 (±1.2) 12.2 (±0.9) 12.6 (±1.3) 0.024
Notes: Continuous variables are presented as mean (±SD) or median [IQR]. P-values are based on T-test and Mann–Whitney U-Test for continuous variables and Chi-square
test for categorical variables. P-values in bold indicate signiﬁcant differences (p<0.05) between groups.
Abbreviations: BMI, Body Mass Index; (i)ADL, (instrumental) Activities of Daily Living; MMSE, Mini–Mental State Examination; GDS, Geriatric Depression Scale; eGFR-BIS,
estimated Glomerular Filtration Rate; TIA/CVA, transient ischemic attack/cerebrovascular accident; COPD, chronic obstructive pulmonary disease; CIRS, Cumulative Illness
Rating Scale; pSBP, peripheral systolic blood pressure; pDBP, peripheral diastolic blood pressure; MAP, mean arterial pressure; pPP, peripheral pulse pressure; cSBP, central
systolic blood pressure; cDBP, central diastolic blood pressure; aPWV, aortic Pulse Wave Velocity; cPP, central Pulse Pressure.
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cannot be excluded that lower quality of life may also have
an effect on aortic stiffness. It has been suggested that lower
quality of life also represents people with lower social
support or more depressive symptoms.42,43 As result of this,
it could be hypothesized that lower quality of life might also
affect (hypertension) treatment compliance and therefore
deterioration of health which negatively affects the function
of the arteries. In addition, lower mobility and the presence of
depressive symptoms and pain may also perpetuate
a physically inactive lifestyle, which is associated with
a change in vascular function and increase in stiffness.44
We found a discrepancy in the results of the EQ-5D
index and the EQ-VAS. This discrepancy could be
explained by the nature of the questionnaires. Noticing
and reporting actual disabilities in daily life in the EQ-
5D index does not necessarily mean that the self-
perceived health on the EQ-VAS is scored as worse.
Namely since in the EQ-VAS, an individual values his
or her health position in life in the context of cultural
0
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Figure 1 Mean values of aortic stiffness according to EQ-5D index status (n=280).
Notes: (A and B): aortic Pulse Wave Velocity (aPWV) in m/s; (C and D): central Pulse Pressure (cPP) in mmHg. Model 1: adjusted for age, sex, mean arterial pressure and
heart rate; Model 2: additionally adjusted for Cumulative Illness Rating Scale total score. Dots represent mean values, bars represent 95% conﬁdence intervals.
Table 2 Characteristics of Health-Related Quality of Life (n=280)
Characteristics
EQ-5D index, score 0.86 [0.81–0.91]
EQ-5D VAS, score 74.9 (±14.8)
No Problems per Dimension
Mobility, % 42.5
Self-care, % 92.5
Daily activities, % 78.9
Pain/discomfort, % 44.6
Anxiety/depression, % 83.6
Note: Continuous variables are presented as mean (±SD) or median [IQR].
Abbreviation: EQ-5D VAS, EQ-5D Visual Analogue Scale.
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and social aspects. In other words, these two question-
naires score different aspects of quality of life. Another
well-known problem with the EQ-VAS is the end-of-
scale bias which results in small numbers of extreme
values, which could make the EQ-VAS less reliable than
the EQ-5D index.
Some aspects of this study need further consideration.
First, the cross-sectional study design does not allow to
draw causal inferences. Second, the sample size was
relatively small and the population consisted of outpati-
ent older persons. This could affect the power to investi-
gate possible associations between aortic stiffness and
quality of life. However, despite the limited number of
participants and the possible selection bias, we were able
to detect signiﬁcant differences with a small effect size
between those with and without problems in quality of
life. The difference in cPP reached statistical signiﬁcance
in adjusted models, which might suggest that this result is
due to chance or that the sample size for this speciﬁc
analysis is underpowered. In a larger and more hetero-
geneous population, these differences might be ampliﬁed.
Third, we measured aortic stiffness with an oscillometric
method. This method is validated and gives reliable
results when compared to invasive measurements,30 how-
ever, the predictive value of this measurement to cardio-
vascular outcomes has not been investigated. One of the
strengths of this study is the fact that we categorized EQ-
5D index into no problem and any problem. The splitting
partly resolved the problem of skewed values, but this
made the results also more relevant in clinical practice.
Another strength is the use of several markers of aortic
stiffness such as aPWV and cPP. These central measures
play a fundamental role in end organ disease and are
therefore accurate and clinically relevant markers.32,37
The association between aortic stiffness and quality of
life has been investigated before. Nevertheless, most
previous studies did not observe an effect on overall
HRQOL but only on the physical component of the
HRQOL.21,23,24,27 Only one study has described an effect
on overall HRQOL.25 However, this study was performed
in a very small sample of 56 patients undergoing surgical
aortic valve replacement. Our study sample differed from
previous studies, since we have focussed on a speciﬁc
population of older patients in late life, whereas the
previous studies have focussed on younger patients or
speciﬁc patient categories.
Conclusion
In conclusion, aortic stiffness was associated with impaired
quality of life in people of 75 years and over. This association
in late life was independent of age and other cardiovascular
risk factors and might be mediated by subclinical vascular
pathology affecting mental and physical health. Future
research is required to establish whether aortic stiffness has
a predictive value for a deterioration in quality of life.
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